TwinBeech Capital’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
TwinBeech Capital's BMY Position: Q4 2025 in Review
TwinBeech Capital sold out of Bristol-Myers Squibb (BMY) in Q4 2025, closing a stake of 484,528 shares — an estimated $21.9M sold.
TwinBeech Capital first reported a position in BMY in Q4 2019 and held it in 12 quarters. The position peaked at $30.9M in Q3 2023. 2,454 funds tracked by Wall St. Rank hold BMY as of Q4 2025.
- TwinBeech Capital reported no remaining Bristol-Myers Squibb position as of Q4 2025 after selling out during the quarter.
- TwinBeech Capital sold 484,528 Bristol-Myers Squibb shares in Q4 2025, an estimated $21.9M.
- TwinBeech Capital first reported a position in Bristol-Myers Squibb in Q4 2019 and held it in 12 quarters.
- TwinBeech Capital's Bristol-Myers Squibb position peaked at $30.9M in Q3 2023.
- 2,454 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2025.
Based on TwinBeech Capital's 13F filing for Q4 2025, filed 17 Feb 2026.